The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Open accessAbstract
Summary: Despite complete or near‐complete suppression of human immunodeficiency virus (HIV) replication with combination antiretroviral therapy, both HIV and chronic inflammation/immune dysfunction persist indefinitely. Untangling the association between the virus and the host immune environment during therapy might lead to novel interventions aimed at either curing the infection or preventing the development of inflammation‐associated end‐organ disease. Chronic inflammation and immune dysfunction might lead to HIV persistence by causing virus production, generating new target cells, enabling infecting of activated and resting target cells, altering the migration patterns of susceptible target cells, increasing the proliferation of infected cells, and preventing normal HIV‐specific clearance mechanisms from function. Chronic HIV production or replication might contribute to persistent inflammation and immune dysfunction. The rapidly evolving data on these issues strongly suggest that a vicious cycle might exist in which HIV persistence causes inflammation that in turn contributes to HIV persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–224 of 224
Massanella, M., Negredo, E., Puig, J., Puertas, M. C., Buzón, M. J., Pérez‐Álvarez, N., Carrillo, J., Clotet, B., Martínez‐Picado, J., & Blanco, J. (2012) · AIDS · doi:10.1097/qad.0b013e328359f20f · Cited by 54
Camargo, J. F., Kulkarni, H. R., Agan, B. K., Gaitán, Á. A., Beachy, L. A., Srinivas, S., He, W., Anderson, S., Marconi, V. C., Dolan, M. J., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/598858 · Cited by 53
Tincati, C., Biasin, M., Bandera, A., Violin, M., Marchetti, G. C., Piacentini, L., Vago, L., Balotta, C., Moroni, M., Franzetti, F., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350901400310 · Cited by 52
Garber, D. A., Silvestri, G., Barry, A. P., Fedanov, A., Kozyr, N. L., McClure, H. M., Montefiori, D. C., Larsen, C. P., Altman, J. D., Staprans, S. I., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19442 · Cited by 51
Kuroda, M. J., Schmitz, J. E., Seth, A., Veazey, R. S., Nickerson, C. E., Lifton, M. A., Dailey, P. J., Forman, M. A., Rácz, P., Tenner‐Racz, K., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1474 · Cited by 48
Lugli, E., Mueller, Y. M., Lewis, M. G., Villinger, F. J., Katsikis, P. D., & Roederer, M. (2011) · Blood · doi:10.1182/blood-2011-05-351155 · Cited by 48
Klatt, N. R., Vinton, C. L., Lynch, R. M., Canary, L., Ho, J., Darrah, P. A., Estes, J. D., Seder, R. A., Moir, S. L., & Brenchley, J. M. (2011) · Blood · doi:10.1182/blood-2011-07-365874 · Cited by 47
Self-citationCanary, L., Vinton, C. L., Morcock, D. R., Pierce, J. B., Estes, J. D., Brenchley, J. M., & Klatt, N. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202319 · Cited by 45
Self-citationTassiopoulos, K., LANDAY, A. L., Collier, A. C., Connick, E., Deeks, S. G., Hunt, P. W., Lewis, D. E., Wilson, C. C., & Bosch, R. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis260 · Cited by 43
Self-citationIannello, A., Boulassel, M., Samarani, S., Tremblay, C. L., Toma, E., Routy, J., & Ahmad, A. (2010) · The Journal of Infectious Diseases · doi:10.1086/650314 · Cited by 43
HIV-Specific CD4+ T Cells May Contribute to Viral Persistence in HIV Controllers
Hunt, P. W., Hatano, H., Sinclair, E., Lee, T.-H., Busch, M. P., Martin, J. N., McCune, J. M., & Deeks, S. G. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq202 · Cited by 42
Self-citationJanbazian, L., Price, D. A., Canderan, G., Filali-Mouhim, A., Asher, T. E., Ambrozak, D. R., Scheinberg, P., Boulassel, M. R., Routy, J., Koup, R. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102610 · Cited by 41
Self-citationHatano, H., Scherzer, R., Wu, Y., Harvill, K., Maka, K., Hoh, R., Sinclair, E., Palmer, S., Martin, J. N., Busch, M. P., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31826e7d0f · Cited by 40
Self-citationPersaud, D., Luzuriaga, K., Ziemniak, C., Muresan, P., Greenough, T. C., Fenton, T., Blackford, A. L., Ferguson, K. C., Neu, N. M., & Cunningham, C. K. (2011) · AIDS · doi:10.1097/qad.0b013e32834cdaba · Cited by 36
Th17 cells in natural SIV hosts
Paiardini, M. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328335c161 · Cited by 34
T regulatory cells and HIV infection.
Sempere, J. M., Soriano, V., & Benito, J. M. (2007) · PubMed · Cited by 31
Foxo3a: An integrator of immune dysfunction during HIV infection
van Grevenynghe, J., Cubas, R. A., DaFonseca, S., Metcalf, T. U., Tremblay, C. L., Trautmann, L., Sékaly, R., Schatzle, J. D., & Haddad, E. K. (2012) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2012.05.008 · Cited by 30
Hayes, T. L., Asmuth, D. M., Critchfield, J. W., Knight, T. H., McLaughlin, B. E., Yotter, T., McConnell, D. H., Garcia, J. C., Pollard, R. B., & Shacklett, B. L. (2012) · AIDS · doi:10.1097/qad.0b013e32835d85b4 · Cited by 30
Stone, S., Price, P., & French, M. A. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00307.x · Cited by 28
Wacleche, V. S., Chomont, N., Gosselin, A., Monteiro, P., Goupil, M., Kared, H., Tremblay, C. L., Bernard, N. F., Boulassel, M., Routy, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032964 · Cited by 20
Self-citationDunham, R. M., Gordon, S. N., Vaccari, M., Piatak, M., Huang, Y., Deeks, S. G., Lifson, J. D., Franchini, G., & McCune, J. M. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0162 · Cited by 19
Self-citationHIV‐1 replication activates CD4+ T cells with specificities for persistent herpes viruses
Haas, A., Rehr, M., Graw, F., Rusert, P., Bossart, W., Kuster, H., Trkola, A., Günthard, H. F., & Oxenius, A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000075 · Cited by 17
KIR/HLA: Genetic Clues for a Role of NK Cells in the Control of HIV
Fadda, L., & Alter, G. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5632-3_3 · Cited by 9
Interleukin 18 and cardiovascular disease in HIV-1 infection: a partner in crime?
Torre, D., & Pugliese, A. (2010) · PubMed · Cited by 7
Cited by
Systemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 868
Self-citationFletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
Self-citationType I Interferon in Chronic Virus Infection and Cancer
Snell, L. M., McGaha, T. L., & Brooks, D. G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.05.005 · Cited by 500
Wada, N. I., Jacobson, L. P., Margolick, J. B., Breen, E. C., Macatangay, B., Penugonda, S., Martínez-Maza, O., & Bream, J. H. (2015) · AIDS · doi:10.1097/qad.0000000000000545 · Cited by 383
HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination
Evans, C., Jones, C. E., & Prendergast, A. J. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00055-4 · Cited by 285
Metadata
- Authors
- Klatt, N. R., Chomont, N., Douek, D. C., & Deeks, S. G.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2013-06-16
- Volume
- 254
- Issue
- 1
- Pages
- 326-342
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2070036973
- Cited by
- 435
- References
- 224
- FWCI
- 3.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.